Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues
出版年份 2009 全文链接
标题
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues
作者
关键词
-
出版物
LEUKEMIA
Volume 23, Issue 10, Pages 1708-1715
出版商
Springer Nature
发表日期
2009-07-30
DOI
10.1038/leu.2009.142
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
- (2009) A. M. Jankowska et al. BLOOD
- Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones
- (2009) Philip A. Beer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells
- (2009) Cristian Bellodi et al. JOURNAL OF CLINICAL INVESTIGATION
- A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response
- (2009) M W Drummond et al. LEUKEMIA
- Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
- (2009) A Tefferi et al. LEUKEMIA
- Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
- (2009) A Hochhaus et al. LEUKEMIA
- TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
- (2009) A Tefferi et al. LEUKEMIA
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
- (2009) Damla Olcaydu et al. NATURE GENETICS
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients
- (2009) A K Samanta et al. ONCOGENE
- Glycogen synthase kinase 3 missplicing contributes to leukemia stem cell generation
- (2009) A. E. Abrahamsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular biology of bcr-abl1-positive chronic myeloid leukemia
- (2008) A. Quintas-Cardama et al. BLOOD
- The yin and yang of lenalidomide
- (2008) N. E. Kay BLOOD
- Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
- (2008) S. Li et al. BLOOD
- Activity of the BH3 mimetic ABT-737 on polycythemia vera erythroid precursor cells
- (2008) A. Zeuner et al. BLOOD
- Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
- (2008) F. X. Schaub et al. BLOOD
- Nuclear translocation of urokinase-type plasminogen activator
- (2008) V. Stepanova et al. BLOOD
- Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation
- (2008) C. G. Mullighan et al. BLOOD
- Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
- (2008) S. Xing et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- Defective homing is associated with altered Cdc42 activity in cells from patients with Fanconi anemia group A
- (2008) X. Zhang et al. BLOOD
- RGT, a synthetic peptide corresponding to the integrin 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin IIb 3 with Src kinase
- (2008) X. Su et al. BLOOD
- Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders
- (2008) Daniela Capello et al. BRITISH JOURNAL OF HAEMATOLOGY
- Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
- (2008) Danilo Perrotti et al. CANCER AND METASTASIS REVIEWS
- Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
- (2008) Christine Dierks et al. CANCER CELL
- New insights into the pathogenesis and treatment of chronic myeloproliferative disorders
- (2008) Ruben A Mesa CURRENT OPINION IN HEMATOLOGY
- Aberrant expression of microRNA in polycythemia vera
- (2008) H. Bruchova et al. HAEMATOLOGICA
- Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders
- (2008) N. Fourouclas et al. HAEMATOLOGICA
- 5-Azacitidine has limited therapeutic activity in myelofibrosis
- (2008) R A Mesa et al. LEUKEMIA
- A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
- (2008) A Quintás-Cardama et al. LEUKEMIA
- PML targeting eradicates quiescent leukaemia-initiating cells
- (2008) Keisuke Ito et al. NATURE
- Inhibition of the Bcl-xLDeamidation Pathway in Myeloproliferative Disorders
- (2008) Rui Zhao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- BCR-ABL-transformed GMP as myeloid leukemic stem cells
- (2008) Y. Minami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimizing Outcomes for Patients With Advanced Disease in Chronic Myelogenous Leukemia
- (2008) Francis J. Giles et al. SEMINARS IN ONCOLOGY
- Hypermethylation ofCXCR4Promoter in CD34+Cells from Patients with Primary Myelofibrosis
- (2008) Costanza Bogani et al. STEM CELLS
- The JAK2V617F Mutation in Polycythemia Vera and Other Myeloproliferative Disorders: One Mutation for Three Diseases?
- (2008) C. James Hematology-American Society of Hematology Education Program
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now